Mandate

Vinge advises EQT Infrastructure II fund on the acquisition of Hector Rail

September 16, 2014

Vinge advises EQT Infrastructure II fund in connection with the acquisition of a majority stake in Hector Rail AB, a leading Sweden-based independent rail freight company, from investment entities advised by Höegh Capital Partners, the founders Mats Nyblom and Ole Kjörrefjord, and other minority owners. Hector Rail was founded in 2004, supported by the Norwegian Høegh family. The Company, headquartered in Stockholm, Sweden, has around 190 employees operating in Sweden, Norway, Denmark and Germany.

Hector Rail offers environmentally friendly transportation services of heavy industry products, raw materials, intermodal freight and passengers to clients such as industrial companies, forwarders, and other rail companies under medium term contracts. The Company currently operates a fleet of around 50 locomotives and 10 shunters performing over 6 million train kilometres per year. Revenues amounted to approximately SEK 630 million in 2013.

Vinge’s team consisted of responsible partner Daniel Rosvall together with, amongst others, project manager Matthias Pannier and associate Maria Dahlin (all corporate).

Related

Vinge has advised Hansa Biopharma in connection with entering into a financing agreement

Vinge has advised Hansa Biopharma AB (publ), a commercial-stage biopharmaceutical company on a mission to develop and commercialize innovative, lifesaving and life-altering treatments for patients with rare immunological conditions, listed on Nasdaq Stockholm, in connection with a U.S. convertible note purchase agreement comprising USD 30 million aggregate principal amount of unsecured convertible senior notes.
March 23, 2026

Vinge advises in connection with data center provider EcoDataCenter’s tap issue of SEK 500 million bonds

Vinge has advised in connection with EcoDC Holding AB (publ)'s tap issue of SEK 500 million senior unsecured bonds under the existing framework of up to SEK 2 billion.
March 19, 2026

Vinge has advised Cinclus Pharma in connection with entering into financing agreement

Vinge has advised Cinclus Pharma Holding AB (publ), a late-stage clinical pharmaceutical company developing next-generation treatments for gastric acid-related diseases listed on Nasdaq Stockholm, in connection with a long-term structured credit agreement for a total of up to EUR 28 million divided into four tranches, of which two are convertibles.
March 16, 2026